About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COMPLETEDPhase 2/3

68Ga-PSMA-11 PET/MRI in Finding Tumors in Patients With Intermediate or High-Risk Prostate Cancer Undergoing Surgery

68Ga-PSMA-11 PET/MRI for Detection of Regional Nodal and Distant Metastases in Patients With Intermediate and High-Risk Prostate Cancer

NCT02678351•Andrei Iagaru

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Stage II Prostate AdenocarcinomaStage III Prostate Adenocarcinoma

Interventions

68Ga-PSMA-11

Magnetic resonance imaging (MRI)

+1 more

Locations

1

United States

Locations (1)

Stanford University, School of Medicine

Palo Alto, California, United States

Key Dates

Start Date

April 18, 2016

Primary Completion Date

December 13, 2020

Completion Date

December 1, 2021

Last Updated

March 4, 2022

Related Studies

COMPLETEDPhase 2

Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide Therapy

NCT02099864

Castration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the Bone+5 more

Hypofractionated Stereotactic Body Radiation Therapy for Patients With Prostate Cancer That Was Removed by Surgery

NCT02446366

Stage II Prostate AdenocarcinomaStage IIB Prostate Cancer+1 more

COMPLETEDPhase 1

PLX3397, Radiation Therapy, and Antihormone Therapy in Treating Patients With Intermediate- or High-Risk Prostate Cancer

NCT02472275

Stage I Prostate AdenocarcinomaStage II Prostate Adenocarcinoma+1 more

COMPLETEDPhase 2

Itraconazole in Treating Patients With Biochemically Relapsed Prostate Cancer

NCT01787331

Prostate AdenocarcinomaRecurrent Prostate Carcinoma+3 more

Sponsors

Lead Sponsor

Andrei Iagaru

Collaborators

National Cancer Institute (NCI)

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 4, 2022Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions